Condensed ring compound and organic light emitting device including the same

文档序号:1682340 发布日期:2020-01-03 浏览:36次 中文

阅读说明:本技术 稠环化合物和包括其的有机发光器件 (Condensed ring compound and organic light emitting device including the same ) 是由 郑妍淑 田顺玉 沼田真树 沈明善 李河燮 印守康 于 2019-02-01 设计创作,主要内容包括:公开稠环化合物和包括其的有机发光器件。所述稠环化合物由式1表示,其中,在式1中,A<Sub>1</Sub>、D<Sub>1</Sub>、和R<Sub>11</Sub>-R<Sub>14</Sub>与说明书中描述的相同。式1<Image he="380" wi="450" file="DDA0001967728330000011.GIF" imgContent="drawing" imgFormat="GIF" orientation="portrait" inline="no"></Image>(Disclosed are a fused ring compound and an organic light emitting device including the same. The condensed ring compound is represented by formula 1, wherein, in formula 1, A 1 、D 1 And R 11 ‑R 14 As described in the specification. Formula 1)

1. A fused ring compound represented by formula 1:

formula 1

Figure FDA0001967728300000011

Formula 2

Figure FDA0001967728300000012

Wherein, in formulae 1, 2, and 3-1 to 3-5,

D1is a group represented by the formula 2,

A1is a group represented by one selected from the group consisting of formulas 3-1 to 3-5,

R11and R12Each independently is substituted or unsubstituted C6-C30An aryl group, a heteroaryl group,

A21and A22Each independently selected from the group consisting of a phenyl group, a fluorene group, a carbazole group, a dibenzofuran group, a dibenzothiophene group, an indolofluorene group, an indolocarbazole group, an indenofluorene group, an indenocarbazole group, an indenodibenzofuran group, an indenodibenzothiophene group, a benzofurofluorene group, a benzofurodibenzofuran group, a benzofurodibenzothiophene group, a benzothienodibenzothiophene group, a benzothienocarbazole group, a benzothienodibenzofuran group, and a benzothienodibenzothiophene group,

X31is N or C (R)31);X32Is N or C (R)32);X33Is N or C (R)33);X34Is N or C (R)34);X35Is N or C (R)35);X36Is N or C (R)36);X37Is N or C (R)37) (ii) a And X38Is N or C (R)38) Wherein X is selected from the group consisting of those in the formula 3-131-X35At least one of (A) is N, and is selected from X in formulae 3-2 to 3-536-X38At least one of (a) is N,

Y31is selected from the group consisting of O and S,

R13、R14、R21、R22and R31-R39Each independently selected from the group consisting of hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxy, cyano, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid group or salt thereof, sulfonic acid group or salt thereof, phosphoric acid group or salt thereof, and substituted or unsubstituted C1-C60Alkyl, substituted or unsubstituted C2-C60Alkenyl, substituted or unsubstituted C2-C60Alkynyl, substituted or unsubstituted C1-C60Alkoxy, substituted or unsubstituted C3-C10Cycloalkyl, substituted or unsubstituted C1-C10Heterocycloalkyl, substituted or unsubstituted C3-C10Cycloalkenyl, substituted or unsubstituted C1-C10Heterocycloalkenyl, substituted or unsubstituted C6-C60Aryl, substituted or unsubstituted C6-C60Aryloxy, substituted or unsubstituted C6-C60Arylthio, substituted or unsubstituted C7-C60Aralkyl, substituted or unsubstituted C1-C60Heteroaryl, substituted or unsubstituted C1-C60Heteroaryloxy, substituted or unsubstituted C1-C60Heteroarylthio, substituted or unsubstituted C2-C60Heteroaralkyl, substituted or unsubstituted monovalent non-aromatic fused polycyclic group, substituted or unsubstituted monovalent non-aromatic fused heteropolycyclic group, -Si (Q)1)(Q2)(Q3)、-N(Q4)(Q5) and-B (Q)6)(Q7),

Is selected from R31-R39Optionally joined to form a fused ring,

b21 and b22 are each independently selected from 1, 2,3, 4,5, 6, 7, and 8,

b39 is selected from 1, 2,3, and 4,

Q1-Q7each independently selected from hydrogen and C1-C60Alkyl radical, C2-C60Alkenyl radical, C2-C60Alkynyl, C1-C60Alkoxy radical, C3-C10Cycloalkyl radical, C1-C10Heterocycloalkyl radical, C3-C10Cycloalkenyl radical, C1-C10Heterocycloalkenyl, C6-C60Aryl radical, C1-C60A heteroaryl group, a monovalent non-aromatic fused polycyclic group, and a monovalent non-aromatic fused heteropolycyclic group, and

denotes the binding site to the adjacent atom.

2. The fused ring compound of claim 1, wherein

R11And R12Each independently selected from:

phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthracyl, benzo [9,10 ]]Phenanthryl, pyrenyl, and

Figure FDA0001967728300000031

phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthracenyl, benzo [9,10 ] substituted by at least one member selected from the group consisting of]Phenanthryl, pyrenyl, and

Figure FDA0001967728300000032

3. The fused ring compound of claim 1, wherein

R11And R12Each independently selected from:

phenyl, biphenyl, terphenyl, and naphthyl; and

phenyl, biphenyl, terphenyl, and naphthyl, each substituted with at least one substituent selected from the group consisting of: deuterium, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl, tert-pentyl, n-hexyl, isohexyl, sec-hexyl, tert-hexyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, and phenyl.

4. The fused ring compound of claim 1, wherein

A21Is a phenyl group, and

A22selected from the group consisting of phenyl groups, fluorene groups, carbazole groups, dibenzofuran groups, dibenzothiophene groups, indolofluorene groups, indolocarbazole groups, indenofluorene groups, indenocarbazole groups, indenodibenzofuran groups, indenodibenzothiophene groups, benzofuranofluorene groups, benzofuranocarbazole groups, benzofuranodibenzofuran groupsA pyran group, a benzofurodibenzothiophene group, a benzothienofluorene group, a benzothienocarbazole group, a benzothienodibenzofuran group, and a benzothienodibenzothiophene group.

5. The fused ring compound of claim 1, wherein

X selected from the group consisting of those in the formula 3-131-X35Two or three of (A) are each independently N and selected from X in formulae 3-2 to 3-536-X38Are each independently N.

6. The fused ring compound of claim 1, wherein

R13And R14Each independently selected from:

hydrogen, deuterium, -F, -Cl, -Br, -I, cyano, phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthracenyl, benzo [9,10 ]]Phenanthryl, pyrenyl, and

Figure FDA0001967728300000033

phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthracenyl, benzo [9,10 ] substituted by at least one member selected from the group consisting of]Phenanthryl, pyrenyl, and

Figure FDA0001967728300000034

7. The fused ring compound of claim 1, wherein

R21And R22Each independently selected from:

hydrogen, deuterium, C1-C20Alkyl radical, C1-C20Alkoxy, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentenyl, cyclohexenyl, phenyl, biphenyl, terphenyl, pentalenyl, indenyl, naphthyl, cyclopentadienyl, phenyl, biphenyl, and naphthyl,

Figure FDA0001967728300000041

c each substituted by at least one member selected from the group consisting of1-C20Alkyl radical, C1-C20Alkoxy, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentenyl, cyclohexenyl, phenyl, biphenyl, terphenyl, pentalenyl, indenyl, naphthyl, cyclopentadienyl, phenyl, biphenyl, and naphthyl,

Figure FDA0001967728300000044

8. The fused ring compound of claim 1, wherein

D1Represented by one selected from formulas 2-1 and 2-2:

Figure FDA0001967728300000051

Figure FDA0001967728300000061

wherein, in the formulae 2-1, 2-2, 9-11, 9-21 to 9-23, and 9-31 to 9-48,

A21are groups represented by the formulae 9 to 11,

A22selected from the group represented by the formulae 9-11, 9-21 to 9-23, and 9-31 to 9-48,

C1-C4each of which is independently a carbon atom,

R21、R22、b21and b22Each independently the same as in formula 2,

X91selected from O, S, N (R)22d) And C (R)22d)(R22e),

X92Selected from O, S, N (R)22f) And C (R)22f)(R22g),

R22a-R22gEach independently of the other with respect to R in formula 222Are the same as described, and

b22a-b22c are each independently the same as described for b22 in formula 2.

9. The fused ring compound of claim 1, wherein

A1Represented by one selected from formulas 3-11 to 3-35:

Figure FDA0001967728300000062

Figure FDA0001967728300000071

Figure FDA0001967728300000081

wherein, in formulae 3-11 to 3-35,

Y31、R31-R39and b39 are each independently the same as in formulae 3-1 to 3-5, and

denotes the binding site to the adjacent atom.

10. The fused ring compound of claim 1, wherein

The fused ring compound represented by formula 1 is represented by formula 1-1:

formula 1-1

Figure FDA0001967728300000082

Wherein, in the formula 1-1,

D1、A1、R11and R12Each independently is the same as in formula 1.

11. The fused ring compound of claim 10 wherein

D1From the group of formula 2One of the representations of-1 and 2-2, and

A1represented by one selected from formulas 3-11 to 3-35:

Figure FDA0001967728300000083

Figure FDA0001967728300000091

Figure FDA0001967728300000101

Figure FDA0001967728300000111

wherein, in formulae 2-1, 2-2, 9-11, 9-21 to 9-23, 9-31 to 9-48, and 3-11 to 3-35,

A21are groups represented by the formulae 9 to 11,

A22selected from the group represented by the formulae 9-11, 9-21 to 9-23, and 9-31 to 9-48,

C1-C4each of which is independently a carbon atom,

R21、R22、b21and b22Each independently the same as in formula 2,

X91selected from O, S, N (R)22d) And C (R)22d)(R22e),

X92Selected from O, S, N (R)22f) And C (R)22f)(R22g),

R22a-R22gEach independently of the other with respect to R in formula 222The same as that described above is true for the description,

b22a-b22c are each independently the same as described for b22 in formula 2,

Y31、R31-R39and b39 are each independently the same as described with respect to formulas 3-1 to 3-5, and

denotes the binding site to the adjacent atom.

12. The fused ring compound of claim 1, wherein

The fused ring compound represented by formula 1 is selected from compounds 1 to 1030:

Figure FDA0001967728300000121

Figure FDA0001967728300000131

Figure FDA0001967728300000141

Figure FDA0001967728300000151

Figure FDA0001967728300000161

Figure FDA0001967728300000181

Figure FDA0001967728300000191

Figure FDA0001967728300000201

Figure FDA0001967728300000211

Figure FDA0001967728300000231

Figure FDA0001967728300000241

Figure FDA0001967728300000261

Figure FDA0001967728300000271

Figure FDA0001967728300000281

Figure FDA0001967728300000291

Figure FDA0001967728300000301

Figure FDA0001967728300000311

Figure FDA0001967728300000321

Figure FDA0001967728300000341

Figure FDA0001967728300000351

Figure FDA0001967728300000371

Figure FDA0001967728300000381

Figure FDA0001967728300000401

Figure FDA0001967728300000411

Figure FDA0001967728300000421

Figure FDA0001967728300000441

Figure FDA0001967728300000451

Figure FDA0001967728300000461

Figure FDA0001967728300000471

13. an organic light emitting device comprising:

a first electrode;

a second electrode; and

an organic layer disposed between the first electrode and the second electrode,

wherein the organic layer comprises an emissive layer, and

wherein the organic layer comprises at least one fused ring compound as recited in any one of claims 1-12.

14. An organic light emissive device according to claim 13, wherein

The first electrode is an anode and the second electrode is a cathode,

the second electrode is a cathode and is a cathode,

the organic layer further includes a hole transport region disposed between the first electrode and the emission layer and an electron transport region disposed between the emission layer and the second electrode,

wherein the hole transport region comprises a hole injection layer, a hole transport layer, an electron blocking layer, or any combination thereof, and

wherein the electron transport region comprises a hole blocking layer, an electron transport layer, an electron injection layer, or any combination thereof.

15. An organic light emissive device according to claim 13, wherein

The emission layer includes the fused ring compound.

16. An organic light emissive device according to claim 15, wherein

A ratio of a fluorescence emission component emitted from the emission layer to a total emission component is 90% or more.

17. An organic light emissive device according to claim 15, wherein

The fused ring compound is a fluorescent emitter, and

a ratio of an emission component emitted from the condensed-cyclic compound to a total emission component emitted from the emission layer is 80% or more.

18. An organic light emissive device according to claim 17, wherein

The emitting layer is composed of the condensed ring compound; or

The emissive layer further comprises a body.

19. An organic light emissive device according to claim 15, wherein

The emissive layer includes a host and a dopant,

the body includes the fused ring compound,

the amount of the host is greater than the amount of the dopant, and

a ratio of an emission component of the dopant to a total emission component emitted from the emission layer is 80% or more.

20. An organic light emissive device according to claim 15, wherein

The emission layer includes a host, an auxiliary dopant, and a main dopant,

the auxiliary dopant includes the fused ring compound, and

a ratio of an emission component of the main dopant to a total emission component emitted from the emission layer is 80% or more.

Technical Field

One or more embodiments relate to a fused ring compound and an organic light emitting device including the same.

Background

Organic Light Emitting Devices (OLEDs) are self-emissive devices that produce full-color images and also have wide viewing angles, high contrast, short response times, and excellent characteristics in terms of luminance, driving voltage, and response speed, compared to other types of devices.

In an example, an organic light emitting device includes an anode, a cathode, and an organic layer disposed between the anode and the cathode and including an emissive layer. A hole transport region may be disposed between the anode and the emissive layer, and an electron transport region may be disposed between the emissive layer and the cathode. Holes supplied from the anode may move toward the emission layer through the hole transport region, and electrons supplied from the cathode may move toward the emission layer through the electron transport region. Carriers such as holes and electrons recombine in the emission layer to generate excitons. These excitons transition from an excited state to a ground state, thereby generating light.

Various types of organic light emitting devices are known. However, there is still a need for OLEDs having low driving voltages, high efficiency, high brightness, and long lifetimes.

Disclosure of Invention

Aspects of the present disclosure provide a fused ring compound having excellent delayed fluorescence emission characteristics and an organic light emitting device including the same and thus having high efficiency and/or long lifetime.

Additional aspects will be set forth in part in the description which follows and, in part, will be obvious from the description, or may be learned by practice of the embodiments provided.

One aspect provides a fused ring compound represented by formula 1:

formula 1

Figure BDA0001967728310000021

Formula 2

Figure BDA0001967728310000022

Figure BDA0001967728310000023

Figure BDA0001967728310000024

In formulae 1, 2, and 3-1 to 3-5,

D1may be a group represented by formula 2,

A1may be a group represented by one selected from the group consisting of formulas 3-1 to 3-5,

R11and R12Each independently may be substituted or unsubstituted C6-C30An aryl group, a heteroaryl group,

A21and A22Each of which is independently selected from a phenyl group, a fluorene group, a carbazole group, a dibenzofuran group, a dibenzothiophene group, an indolofluorene group, an indolocarbazole group, an indenofluorene group, an indenocarbazole group, an indenodibenzofuran group, an indenodibenzothiophene group, a benzofurofluorene group, a benzofurodibenzofuran group, a benzofurodibenzothiophene group, a benzothienodibenzothiophene group, a benzothienocarbazole group, a benzothienodibenzofuran group, and a benzothienodibenzothiophene group,

X31can be N or C (R)31);X32Can be N or C (R)32);X33Can be N or C (R)33);X34Can be N or C (R)34);X35Can be N or C (R)35);X36Can be N or C (R)36);X37Can be N or C (R)37) (ii) a And X38Can be N or C (R)38) Wherein X is selected from the group consisting of those in the formula 3-131-X35At least one of (A) and (B) may be N, and is selected from X in formulae 3-2 to 3-536-X38At least one of (a) may be N,

Y31can be selected from the group consisting of O and S,

R13、R14、R21、R22and R31-R39Can be independently selected from hydrogen, deuterium, -F, -Cl and-Br, -I, hydroxy, cyano, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid group or salt thereof, sulfonic acid group or salt thereof, phosphoric acid group or salt thereof, substituted or unsubstituted C1-C60Alkyl, substituted or unsubstituted C2-C60Alkenyl, substituted or unsubstituted C2-C60Alkynyl, substituted or unsubstituted C1-C60Alkoxy, substituted or unsubstituted C3-C10Cycloalkyl, substituted or unsubstituted C1-C10Heterocycloalkyl, substituted or unsubstituted C3-C10Cycloalkenyl, substituted or unsubstituted C1-C10Heterocycloalkenyl, substituted or unsubstituted C6-C60Aryl, substituted or unsubstituted C6-C60Aryloxy, substituted or unsubstituted C6-C60Arylthio, substituted or unsubstituted C7-C60Aralkyl, substituted or unsubstituted C1-C60Heteroaryl, substituted or unsubstituted C1-C60Heteroaryloxy, substituted or unsubstituted C1-C60Heteroarylthio, substituted or unsubstituted C2-C60Heteroaralkyl, substituted or unsubstituted monovalent non-aromatic fused polycyclic group, substituted or unsubstituted monovalent non-aromatic fused heteropolycyclic group, -Si (Q)1)(Q2)(Q3)、-N(Q4)(Q5) and-B (Q)6)(Q7),

Is selected from R31-R39May optionally be joined to form a fused ring,

b21 and b22 may each be independently selected from 1, 2,3, 4,5, 6, 7, and 8,

b39 may be selected from 1, 2,3, and 4,

Q1-Q7can be independently selected from hydrogen and C1-C60Alkyl radical, C2-C60Alkenyl radical, C2-C60Alkynyl, C1-C60Alkoxy radical, C3-C10Cycloalkyl radical, C1-C10Heterocycloalkyl radical, C3-C10Cycloalkenyl radical, C1-C10Heterocycloalkenyl, C6-C60Aryl radical, C1-C60A heteroaryl group, a monovalent non-aromatic fused polycyclic group, and a monovalent non-aromatic fused heteropolycyclic group, and

denotes the binding site to the adjacent atom.

Another aspect provides an organic light emitting device comprising:

a first electrode;

a second electrode; and

an organic layer disposed between the first electrode and the second electrode,

wherein the organic layer comprises an emissive layer, and

wherein the organic layer comprises at least one fused ring compound described above.

Drawings

These and/or other aspects will become apparent and more readily appreciated from the following description of embodiments, taken in conjunction with fig. 1, which is a schematic view of an organic light emitting device according to an embodiment.

Detailed Description

Reference will now be made in detail to the embodiments, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to like elements throughout. In this regard, the present embodiments may have different forms and should not be construed as limited to the descriptions set forth herein. Accordingly, the embodiments are described below only by referring to the drawings to illustrate aspects of the present disclosure. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items. The expression "at least one of" when preceding or following a list of elements modifies the entire list of elements without modifying individual elements of the list.

It will be understood that when an element is referred to as being "on" another element, it can be in direct contact with the other element or intervening elements may be present. In contrast, when an element is referred to as being "directly on" another element, there are no intervening elements present.

It will be understood that, although the terms first, second, third, etc. may be used herein to describe various elements, components, regions, layers and/or sections, these elements, components, regions, layers and/or sections should not be limited by these terms. These terms are only used to distinguish one element, component, region, layer or section from another element, component, region, layer or section. Thus, a first element, component, region, layer or section discussed below could be termed a second element, component, region, layer or section without departing from the teachings of the present embodiments.

The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting. As used herein, the singular forms "a", "an" and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise.

The term "or" means "and/or". It will be further understood that the terms "comprises" and/or "comprising," when used in this specification, specify the presence of stated features, regions, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, regions, integers, steps, operations, elements, components, and/or groups thereof.

Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this general inventive concept belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and the present disclosure, and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.

Exemplary embodiments are described herein with reference to cross-sectional views that are schematic illustrations of idealized embodiments. As such, deviations from the shapes of the figures as a result, for example, of manufacturing techniques and/or tolerances, are to be expected. Thus, the embodiments described herein should not be construed as limited to the particular shapes of regions as illustrated herein but are to include deviations in shapes that result, for example, from manufacturing. For example, regions illustrated or described as flat may typically have rough and/or non-linear features. Further, the illustrated sharp corners may be rounded. Thus, the regions illustrated in the figures are schematic in nature and their shapes are not intended to illustrate the precise shape of a region and are not intended to limit the scope of the present claims.

As used herein, "about" or "approximately" includes the stated value and is meant to be within an acceptable range of deviation for the particular value as determined by one of ordinary skill in the art in view of the measurement in question and the error associated with measurement of the particular quantity (i.e., limitations of the measurement system). For example, "about" may mean a deviation from the stated value in one or more deviation ranges, or in a range of ± 10% or 5%.

One aspect of the present disclosure provides a fused ring compound represented by formula 1, wherein D in formula 11May be a group represented by formula 2, and A in formula 11May be a group represented by one selected from formulas 3-1 to 3-5:

formula 1

Figure BDA0001967728310000051

Formula 2

Figure BDA0001967728310000061

Figure BDA0001967728310000062

Figure BDA0001967728310000063

Formulas 1, 2, and 3-1 to 3-5 will be described below.

R in formula 111And R12Each independently may be substituted or unsubstituted C6-C30And (4) an aryl group.

In one embodiment, formulaR in 111And R12May each be independently selected from:

phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthracyl, benzo [9,10 ]]Phenanthryl, pyrenyl, and

Figure BDA0001967728310000064

a group; and

phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthracenyl, benzo [9,10 ] substituted by at least one member selected from the group consisting of]Phenanthryl, pyrenyl, andbase: deuterium, -F, -Cl, -Br, -I, cyano, C1-C20Alkyl radical, C1-C20Alkoxy, and phenyl, but embodiments of the present disclosure are not limited thereto.

In one or more embodiments, R in formula 111And R12May each be independently selected from:

phenyl, biphenyl, terphenyl, and naphthyl; and

phenyl, biphenyl, terphenyl, and naphthyl, each substituted with at least one substituent selected from the group consisting of: deuterium, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl, tert-pentyl, n-hexyl, isohexyl, sec-hexyl, tert-hexyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, and phenyl, although embodiments of the present disclosure are not so limited.

In one or more embodiments, R in formula 111And R12May each be independently selected from:

a phenyl group; and

a phenyl group substituted by at least one selected from the group consisting of a methyl group, an ethyl group, a n-propyl group, an isopropyl group, a n-butyl group, an isobutyl group, a sec-butyl group, a tert-butyl group, and a phenyl group, but the embodiments of the present disclosure are not limited thereto.

A in formula 221And A22Can be independently selected from phenyl group, fluorene group, carbazole group, and diphenyl groupAn benzofuran group, a dibenzothiophene group, an indolofluorene group, an indolocarbazole group, an indenofluorene group, an indenocarbazole group, an indenodibenzofuran group, an indenodibenzothiophene group, a benzofurofluorene group, a benzofurocarbazole group, a benzofurodibenzofuran group, a benzofurodibenzothiophene group, a benzothienofluorene group, a benzothienocarbazole group, a benzothienodibenzofuran group, and a benzothienodibenzothiophene group.

In one embodiment, in formula 2,

A21it may be a phenyl group or a substituted phenyl group,

A22may be selected from the group consisting of a phenyl group, a fluorene group, a carbazole group, a dibenzofuran group, a dibenzothiophene group, an indolofluorene group, an indolocarbazole group, an indenofluorene group, an indenocarbazole group, an indenodibenzofuran group, an indenodibenzothiophene group, a benzofurofluorene group, a benzofurodibenzofuran group, a benzofurodibenzothiophene group, a benzothienodibenzothiophene group, a benzothienodibenzofuran group, and a benzothienodibenzothiophene group, although embodiments of the present disclosure are not limited thereto.

In formulae 3-1 to 3-5, X31Can be N or C (R)31);X32Can be N or C (R)32);X33Can be N or C (R)33);X34Can be N or C (R)34);X35Can be N or C (R)35);X36Can be N or C (R)36);X37Can be N or C (R)37) (ii) a And X38Can be N or C (R)38) Wherein X is selected from the group consisting of those in the formula 3-131-X35At least one of (A) and (B) may each independently be N and is selected from X in formulae 3-2 to 3-536-X38May each independently be N.

In one embodiment, X is selected from those in formula 3-131-X35Two or three of (A) may each independently be N, and is selected from X in formulae 3-2 to 3-536-X38May each be independently N, but embodiments of the present disclosure are not limited thereto.

In formulae 3-2 to 3-5, Y31Can be selected from O and S.

In formulae 1, 2, and 3-1 to 3-5, R13、R14、R21、R22And R31-R39Each independently selected from hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxy, cyano, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid group or salt thereof, sulfonic acid group or salt thereof, phosphoric acid group or salt thereof, and substituted or unsubstituted C1-C60Alkyl, substituted or unsubstituted C2-C60Alkenyl, substituted or unsubstituted C2-C60Alkynyl, substituted or unsubstituted C1-C60Alkoxy, substituted or unsubstituted C3-C10Cycloalkyl, substituted or unsubstituted C1-C10Heterocycloalkyl, substituted or unsubstituted C3-C10Cycloalkenyl, substituted or unsubstituted C1-C10Heterocycloalkenyl, substituted or unsubstituted C6-C60Aryl, substituted or unsubstituted C6-C60Aryloxy, substituted or unsubstituted C6-C60Arylthio, substituted or unsubstituted C7-C60Aralkyl, substituted or unsubstituted C1-C60Heteroaryl, substituted or unsubstituted C1-C60Heteroaryloxy, substituted or unsubstituted C1-C60Heteroarylthio, substituted or unsubstituted C2-C60Heteroaralkyl, substituted or unsubstituted monovalent non-aromatic fused polycyclic group, substituted or unsubstituted monovalent non-aromatic fused heteropolycyclic group, -Si (Q)1)(Q2)(Q3)、-N(Q4)(Q5) and-B (Q)6)(Q7),

Is selected from R31-R39Two adjacent groups of (a) may optionally be linked to each other to form a fused ring, and

Q1-Q7can be independently selected from hydrogen and C1-C60Alkyl radical, C2-C60Alkenyl radical, C2-C60Alkynyl, C1-C60Alkoxy radical, C3-C10Cycloalkyl radical, C1-C10Heterocycloalkyl radical, C3-C10Cycloalkenyl radical, C1-C10Heterocycloalkenyl, C6-C60Aryl radical, C1-C60A heteroaryl group, a monovalent non-aromatic fused polycyclic group, and a monovalent non-aromatic fused heteropolycyclic group.

In one embodiment, in formula 1, R13And R14May each be independently selected from:

hydrogen, deuterium, -F, -Cl, -Br, -I, cyano, phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthracenyl, benzo [9,10 ]]Phenanthryl, pyrenyl, and

Figure BDA0001967728310000081

a group; and

phenyl, biphenyl, terphenyl, naphthyl, phenanthryl, anthracenyl, benzo [9,10 ] substituted by at least one member selected from the group consisting of]Phenanthryl, pyrenyl, and

Figure BDA0001967728310000082

base: deuterium, -F, -Cl, -Br, -I, cyano, C1-C20Alkyl radical, C1-C20Alkoxy, and phenyl, but embodiments of the present disclosure are not limited thereto.

In one or more embodiments, R in formula 113And R14May each be independently selected from:

hydrogen, deuterium, -F, -Cl, -Br, -I, cyano, phenyl, biphenyl, terphenyl, and naphthyl; and

phenyl, biphenyl, terphenyl, and naphthyl, each substituted with at least one substituent selected from the group consisting of: deuterium, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, n-pentyl, isopentyl, sec-pentyl, tert-pentyl, n-hexyl, isohexyl, sec-hexyl, tert-hexyl, methoxy, ethoxy, propoxy, butoxy, pentoxy, and phenyl, although embodiments of the present disclosure are not so limited.

In one or more embodiments, R in formula 113And R14May be hydrogen, but embodiments of the present disclosure are not limited thereto.

In one embodiment, R in formula 221And R22Can be independently selected from hydrogen, deuterium, cyano, C1-C20Alkyl radical, C1-C20Alkoxy, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentenyl, cyclohexenyl, phenyl, biphenyl, terphenyl, pentalenyl, indenyl, naphthyl, azulenyl, heptalenyl, indacenaphthenyl, acenaphthenyl, fluorenyl, spiro-dibenzofluorenyl, benzofluorenyl, dibenzofluorenyl, phenaenyl, phenanthrenyl, anthracenyl, fluoranthenyl, benzo [9,10 ] benzo]Phenanthryl, pyrenyl,

Figure BDA0001967728310000091

A group selected from the group consisting of a phenyl group, a tetracenyl group, a picenyl group, a perylene group, a pentylene group, a hexacenyl group, a pentacenyl group, a rubicene group, a coronene group, an egg phenyl group, a pyrrolyl group, a furyl group, a thienyl group, an indolyl group, a benzofuryl group, a benzothienyl group, a carbazolyl group, a dibenzofuryl group, a dibenzothienyl group, a benzocarbazolyl group, a naphthobenzofuryl group, a naphthobenzothienyl group, a dibenzocarbazolyl group, a dinaphthofuranyl group, a dinaphthothiophenyl group, an indolocarbazolyl group, an indodibenzofuryl group, and an indolophthalylbenzothienyl group; and

c each substituted by at least one member selected from the group consisting of1-C20Alkyl radical, C1-C20Alkoxy, cyclopentyl, cyclohexyl, cycloheptyl, cyclopentenyl, cyclohexenyl, phenyl, biphenyl, terphenyl, pentalenyl, indenyl, naphthyl, azulenyl, heptalenyl, indacenaphthenyl, acenaphthenyl, fluorenyl, spiro-dibenzofluorenyl, benzofluorenyl, dibenzofluorenyl, phenaenyl, phenanthrenyl, anthracenyl, fluoranthenyl, benzo [9,10 ] benzo]Phenanthryl, pyrenyl,

Figure BDA0001967728310000092

A group selected from the group consisting of a phenyl group, a tetracenyl group, a picenyl group, a perylene group, a pentylene group, a hexacenyl group, a pentacenyl group, a rubicene group, a coronene group, an egg phenyl group, a pyrrolyl group, a furyl group, a thienyl group, an indolyl group, a benzofuryl group, a benzothienyl group, a carbazolyl group, a dibenzofuryl group, a dibenzothienyl group, a benzocarbazolyl group, a naphthobenzofuryl group, a naphthobenzothienyl group, a dibenzocarbazolyl group, a dinaphthofuranyl group, a dinaphthothiophenyl group, an indolocarbazolyl group, an indodibenzofuryl group, and an indolophthalylbenzothienyl group: deuterium, C1-C20Alkyl radical, C1-C20Alkoxy, phenyl, biphenyl, terphenyl, naphthyl, fluorenyl, dimethylfluorenyl, diphenylfluorenyl, carbazolyl, phenylcarbazolyl, biphenylcarbazolyl, dibenzofuranyl, and dibenzothiophenyl, although embodiments of the present disclosure are not limited thereto.

In one or more embodiments, R in formula 221And R22May each be independently selected from:

hydrogen, deuterium, cyano, C1-C20Alkyl radical, C1-C20Alkoxy, phenyl, biphenyl, terphenyl, naphthyl, fluorenyl, dimethylfluorenyl, diphenylfluorenyl, carbazolyl, phenylcarbazolyl, biphenylcarbazolyl, dibenzofuranyl, and dibenzothiophenyl; and

at least one substituted phenyl and carbazolyl group each selected from the group consisting of: cyano radicals, C1-C20Alkyl groups, and phenyl groups, but embodiments of the present disclosure are not limited thereto.

In one embodiment, R in formulas 3-1 to 3-531-R39May each be independently selected from:

hydrogen, phenyl, biphenyl, terphenyl, naphthyl, dibenzofuranyl, dibenzothiophenyl, pyridyl, pyrimidinyl, pyrazinyl, triazinyl, azabenzofuranyl, azabenzothiophenyl, diazabenzodibenzofuranyl, and diazabenzophenyl; and

phenyl, biphenyl, terphenyl, naphthyl, dibenzofuranyl, bis substituted with at least one substituent each selected fromBenzothienyl, pyridyl, pyrimidinyl, pyrazinyl, triazinyl, azabicyclofuranyl, azabicycloheptanenyl, diaza dibenzofuranyl, and diaza dibenzothienyl: deuterium, -F, -Cl, -Br, -I, cyano, C1-C20Alkyl radical, C1-C20Alkoxy, and phenyl, but embodiments of the present disclosure are not limited thereto.

In one or more embodiments, R in formulas 3-1 through 3-531-R39May each be independently selected from:

hydrogen, phenyl, biphenyl, terphenyl, dibenzofuranyl, dibenzothienyl, pyridyl, azabiphenyl, diaza dibenzofuranyl, and diaza dibenzothienyl; and

phenyl, biphenyl, terphenyl, dibenzofuranyl, dibenzothienyl, azabiphenyl, diaza dibenzothienyl, and diaza dibenzothienyl, each substituted with a phenyl group, although embodiments of the present disclosure are not limited thereto.

For example, D in formula 11May be represented by one selected from formulas 2-1 and 2-2, but the embodiments of the present disclosure are not limited thereto:

Figure BDA0001967728310000101

in formulae 2-1, 2-2, 9-11, 9-21 to 9-23, and 9-31 to 9-48,

A21may be a group represented by the formula 9 to 11,

A22may be a group represented by one selected from the group consisting of formulas 9-11, 9-21 to 9-23, and 9-31 to 9-48,

C1-C4may each independently be a carbon atom,

R21、R22、b21and b22May be each independently the same as in formula 2,

X91can be selected from O, S, N (R)22d) And C (R)22d)(R22e),

X92Can be selected from O, S, N (R)22f) And C (R)22f)(R22g),

R22a-R22gMay each independently have R in the formula 222Is defined the same as that of (A), and

b22a-b22c may each independently have the same definition as b22 in formula 2.

For example, A in formula 11May be represented by one selected from formulas 3-11 to 3-35, but the embodiments of the present disclosure are not limited thereto:

Figure BDA0001967728310000121

in formulae 3-11 to 3-35,

Y31、R31-R39and b39 may each independently have the same definitions as those of formulae 3-1 to 3-5, and

denotes the binding site to the adjacent atom.

In one embodiment, A in formula 11May be represented by one selected from formulae 3-14, 3-15, 3-17, 3-21, 3-25, 3-29, 3-33, 3-34, and 3-35, but the embodiment of the present disclosure is not limited thereto.

For example, the fused ring compound represented by formula 1 may be represented by formula 1-1, but embodiments of the present disclosure are not limited thereto:

formula 1-1

Figure BDA0001967728310000141

In the formula 1-1, the compound represented by the formula,

D1、A1、R11and R12May each independently have the same definitions as those in formula 1.

In one embodiment, in formula 1-1,

D1may be represented by one selected from the group consisting of formulas 2-1 and 2-2,

A1may be represented by one selected from the group consisting of formulas 3-11 to 3-35, and

R11and R12May each independently have the same definitions as those in formula 1:

Figure BDA0001967728310000142

Figure BDA0001967728310000151

Figure BDA0001967728310000161

Figure BDA0001967728310000171

in formulae 2-1, 2-2, 9-11, 9-21 to 9-23, 9-31 to 9-48, and 3-11 to 3-35,

A21may be a group represented by the formula 9 to 11,

A22may be a group represented by one selected from the group consisting of formulas 9-11, 9-21 to 9-23, and 9-31 to 9-48,

C1-C4may each independently be a carbon atom,

R21、R22、b21and b22May be each independently the same as in formula 2,

X91can be selected from O, S, N (R)22d) And C (R)22d)(R22e),

X92Can be selected from O, S, N (R)22f) And C (R)22f)(R22g),

R22a-R22gMay each independently have R in the formula 222Are defined in the same way as in (a),

b22a-b22c may each independently have the same definition as b22 in formula 2,

Y31、R31-R39and b39 may each independently have the same definitions as those described in formulas 3-1 to 3-5, and

denotes the binding site to the adjacent atom.

In one embodiment, the condensed-ring compound represented by formula 1 may be selected from compounds 1 to 1030, but embodiments of the present disclosure are not limited thereto:

Figure BDA0001967728310000181

Figure BDA0001967728310000201

Figure BDA0001967728310000211

Figure BDA0001967728310000221

Figure BDA0001967728310000231

Figure BDA0001967728310000241

Figure BDA0001967728310000261

Figure BDA0001967728310000271

Figure BDA0001967728310000281

Figure BDA0001967728310000291

Figure BDA0001967728310000301

Figure BDA0001967728310000311

Figure BDA0001967728310000321

Figure BDA0001967728310000331

Figure BDA0001967728310000341

Figure BDA0001967728310000361

Figure BDA0001967728310000381

Figure BDA0001967728310000391

Figure BDA0001967728310000401

Figure BDA0001967728310000421

Figure BDA0001967728310000431

Figure BDA0001967728310000441

Figure BDA0001967728310000451

Figure BDA0001967728310000471

Figure BDA0001967728310000481

Figure BDA0001967728310000491

Figure BDA0001967728310000501

Figure BDA0001967728310000511

Figure BDA0001967728310000521

the fused ring compound represented by formula 1 may include a group (A) represented by one selected from formulas 3-1 to 3-5 and capable of serving as an electron acceptor group1) And a group (D) represented by formula 2 and capable of serving as an electron donor group1). Thus, in the fused ring compound represented by formula 1, HOMO and LUMO may be spatially separated from each other, and thus Δ EST(at the lowest excited singlet energy level (E)S1) And lowest excited triplet energy level (E)T1) The difference therebetween) can be reduced. Therefore, the fused ring compound represented by formula 1 may cause reverse intersystem crossing (RISC) even at low temperatures (e.g., room temperature).

R in formula 111And R12Is substituted or unsubstituted C6-C30And (4) an aryl group. Thus, the compound represented by formula 1 includes D1And comprises A1Is increased (i.e., includes D)1And comprises A1Planar twist) of the fused ring compound, the difference between the lowest excited singlet level and the lowest excited triplet level of the fused ring compound represented by formula 1 can be reduced. Accordingly, the fused ring compound represented by formula 1 may have high RISC efficiency, so that an electronic device, such as an organic light emitting device, including the fused ring compound may have high efficiency and/or long lifetime.

The fused ring compound represented by formula 1 may satisfy the following equation 1:

equation 1

0eV<ΔEST≤0.5eV。

In the case of the equation 1, the,

ΔESTis at the lowest excited singlet energy level (E) of the fused ring compound represented by formula 1S1) And minimum excitation of the fused ring compound represented by formula 1Triplet energy level (E)T1) The difference between them. ET1And ES1Was evaluated by the DFT method using a Gaussian program with structure optimization at the level of B3LYP/6-31G (d, p).

In one embodiment, the fused ring compound represented by formula 1 may satisfy equation 1-1, but embodiments of the present disclosure are not limited thereto:

equation 1-1

0.01eV<ΔEST≤0.3eV。

The lowest excited singlet energy level of the fused ring compound represented by formula 1 may be in a range of about 2.5 electron volts (eV) to about 3.0eV, but embodiments of the present disclosure are not limited thereto.

In addition, D in the fused ring compound represented by formula 11And A1May be attached at the "para" position of the phenylene group. Therefore, the condensed ring compound represented by formula 1 has high oscillator strength, and an electronic device such as an organic light emitting device including the condensed ring compound may have high light emitting efficiency.

For example, some compounds were evaluated for HOMO, LUMO, and T levels by the DFT method using a Gaussian program (structurally optimized at the level of B3LYP/6-31G (d, p))1Energy level, S1Energy level, and oscillator strength, and the results thereof are shown in table 1.

TABLE 1

Figure BDA0001967728310000541

Referring to table 1, it was confirmed that the fused ring compound represented by formula 1 had a small difference between the singlet level and the triplet level and a large oscillator strength. Therefore, an electronic device, such as an organic light-emitting device, including the fused ring compound represented by formula 1 may have high light-emitting efficiency.

The synthetic method of the fused ring compound represented by formula 1 may be recognized by one of ordinary skill in the art by referring to the synthetic examples provided below.

The fused ring compound of formula 1 is useful as a material for electronic devices such as organic light emitting devices. According to another aspect of the exemplary embodiments, an organic light emitting device includes: a first electrode, a second electrode, and an organic layer disposed between the first electrode and the second electrode, wherein the organic layer includes an emission layer and at least one of the above-described fused ring compounds represented by formula 1.

The organic light emitting device may have a low driving voltage, high efficiency, high luminance, high quantum emission efficiency, and a long lifetime due to the inclusion of the organic layer including the fused ring compound represented by formula 1.

The condensed-cyclic compound of formula 1 may be used between an electrode pair of an organic light emitting device. For example, the fused ring compound may be included in at least one selected from: an emission layer, a hole transport region (including, for example, at least one of a hole injection layer, a hole transport layer, a buffer layer, and an electron blocking layer) disposed between the first electrode and the emission layer, and an electron transport region (including, for example, at least one selected from a hole blocking layer, an electron transport layer, and an electron injection layer) disposed between the emission layer and the second electrode.

The emission layer of the organic light emitting device may be implemented according to embodiment mode 1, 2, or 3 depending on the use of the fused ring compound represented by formula 1.

140页详细技术资料下载
上一篇:一种医用注射器针头装配设备
下一篇:EGFR抑制剂及其制备和应用

网友询问留言

已有0条留言

还没有人留言评论。精彩留言会获得点赞!

精彩留言,会给你点赞!